Flunarizine Hydrochloride Tablets

This product is a calcium channel blocker. It can prevent cell damage caused by pathological calcium overload in cells due to ischemia and other reasons. This product has the following effects: 1. It relieves vasospasm and has a lasting inhibitory effect on persistent vasospasm caused by vasoconstrictor substances, especially on the basilar artery and internal carotid artery. Its effect is 15 times stronger than that of cerbrine; 2. It has vestibular inhibitory effect, which can increase the blood flow of cochlear arterioles and improve the circulation of vestibular organs; 3. It has anti-epileptic effect, which can block the pathological calcium overload of nerve cells and prevent paroxysmal depolarization and cell discharge, thereby avoiding epileptic seizures; 4. It protects the myocardium and significantly reduces ischemic myocardial damage; 5. Flunarizine also has the effect of improving renal function and can be used for chronic renal failure; in addition, this product also has anti-histamine effect.

Main ingredient: Flunarizine hydrochloride. Molecular formula: C26H26F2N2·2HCl Molecular weight: 477.42

This product is white tablets.

1. Insufficient blood supply to the brain, vertebral artery ischemia, cerebral thrombosis, etc. 2. Tinnitus, dizziness. 3. Prevention of migraine. 4. Auxiliary treatment of epilepsy.

Oral administration: 6-12 mg (1-2 tablets each time), once a day, before bedtime.

1. Adverse reactions of the central nervous system include: ① Drowsiness and fatigue are the most common; ② Depression may occur in long-term users, which is more common in female patients; ③ Extrapyramidal symptoms, manifested as involuntary movements, mandibular movement disorders, rigidity, etc. Most of them appear after 3 weeks of medication and disappear after stopping the medication. It is more likely to occur in the elderly; ④ A small number of patients may experience insomnia, anxiety and other symptoms. 2. Gastrointestinal symptoms are manifested as: burning sensation in the stomach, hyperappetite, increased food intake, and weight gain. 3. Others: A small number of patients may experience rash, dry mouth, galactorrhea, muscle aches and other symptoms. But most of them are transient and can be relieved by stopping the medication.

This drug is contraindicated in patients with a history of allergy to the drug, a history of depression, or acute cerebral hemorrhage.

Precautions for children: Since this drug can pass through the blood-brain barrier, it has clear adverse reactions in the central nervous system, and the central nervous system of children is sensitive to drugs and has relatively weak metabolic functions. Although there is no detailed research data on children's use, in principle, children should be cautious or avoid using this drug. Precautions for pregnancy and lactation: Since this drug can pass through the placental barrier and can be secreted with breast milk, although there are no reports of teratogenicity and effects on embryonic development, in principle, pregnant and lactating women should not use this drug. Precautions for the elderly: Since the nervous system of elderly patients is more sensitive and their metabolic capacity is weaker, the dosage should be reduced as appropriate.

1. When used in combination with alcohol, hypnotics or sedatives, the sedative effect is aggravated. 2. When used in combination with phenytoin sodium and carbamazepine, the blood concentration of flunarizine can be reduced. 3. When flunarizine is used in combination with radiotherapy patients, it can increase the killing power of tumor cells. 4. On the basis of anti-epileptic drug treatment, the addition of flunarizine can improve the anti-epileptic effect.

Protect from light, seal tightly, and store in a cool and dry place.

5mg (calculated as flunarizine)

24 months

Guangdong Lingnan Pharmaceutical Co., Ltd.

• Founded in:

  1991-04-12

• Address:

  No. 5, Muxi 8th Road, Xilian Town, Wujiang District, Shaoguan City

• Tax NO.:

  91440000190333956C

• Registered Funds:

  11.38 million yuan

• Website:

  Log in to view

• Email:

  Log in to view